Kinarus Therapeutics Holding AG (XSWX:KNRS) EV-to-EBITDA : -35.35 (As of Jun. 19, 2024)

Kinarus Therapeutics Holding AG EV-to-EBITDA Chart

Kinarus Therapeutics Holding AG Annual Data
	Trend	Dec12	Dec13	Dec14	Dec15	Dec16	Dec17	Dec18	Dec19	Dec20	Dec21
EV-to-EBITDA		Get a 7-Day Free Trial					-33.94	-1.66	-4.35	1,859.93	-99.35

Kinarus Therapeutics Holding AG Semi-Annual Data
	Jun12	Dec12	Jun13	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21
EV-to-EBITDA	Get a 7-Day Free Trial															-4.35	-	1,859.93	-	-99.35

Competitive Comparison of Kinarus Therapeutics Holding AG's EV-to-EBITDA

For the Airports & Air Services subindustry, Kinarus Therapeutics Holding AG's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Kinarus Therapeutics Holding AG's EV-to-EBITDA Distribution in the Transportation Industry

For the Transportation industry and Industrials sector, Kinarus Therapeutics Holding AG's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Kinarus Therapeutics Holding AG's EV-to-EBITDA falls into.

Kinarus Therapeutics Holding AG EV-to-EBITDA Calculation

Kinarus Therapeutics Holding AG's EV-to-EBITDA for today is calculated as:

Kinarus Therapeutics Holding AG's current Enterprise Value is CHF4.60 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Kinarus Therapeutics Holding AG's EBITDA for the trailing twelve months (TTM) ended in Dec. 2021 was CHF-0.13 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kinarus Therapeutics Holding AG  (XSWX:KNRS) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Kinarus Therapeutics Holding AG's PE Ratio (TTM) for today is calculated as:

Kinarus Therapeutics Holding AG's share price for today is CHF0.0262.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Kinarus Therapeutics Holding AG's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2021 was CHF-0.001.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).

Please read Which price ratio outperforms the enterprise multiple?

Kinarus Therapeutics Holding AG EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Kinarus Therapeutics Holding AG's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Kinarus Therapeutics Holding AG (XSWX:KNRS) Business Description